5 Considerations When Moving From Big Pharma To Biotech
Source: Life Science Leader
By Bill Hinshaw
I’ve had a fulfilling 25-year career in the pharmaceutical industry. During that time, I’ve worked for a couple of powerhouse companies, including Novartis, where I spent 15 years leading business units for oncology, transplant, infectious disease, specialty pharmaceuticals, consumer healthcare, over-the-counter, generics, and vaccines. Over the past decade there has been a tremendous amount of innovation happening in the startup realm, which piqued my interest in making a career move and in bringing cutting-edge therapies to patients in need.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more